Design principles of collateral sensitivity-based dosing strategies
Collateral sensitivity (CS)-based antibiotic treatments, where increased resistance to one antibiotic leads to increased sensitivity to a second antibiotic, may have the potential to limit the emergence of antimicrobial resistance. However, it remains unclear how to best design CS-based treatment sc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479078/ https://www.ncbi.nlm.nih.gov/pubmed/34584086 http://dx.doi.org/10.1038/s41467-021-25927-3 |
_version_ | 1784576168887844864 |
---|---|
author | Aulin, Linda B. S. Liakopoulos, Apostolos van der Graaf, Piet H. Rozen, Daniel E. van Hasselt, J. G. Coen |
author_facet | Aulin, Linda B. S. Liakopoulos, Apostolos van der Graaf, Piet H. Rozen, Daniel E. van Hasselt, J. G. Coen |
author_sort | Aulin, Linda B. S. |
collection | PubMed |
description | Collateral sensitivity (CS)-based antibiotic treatments, where increased resistance to one antibiotic leads to increased sensitivity to a second antibiotic, may have the potential to limit the emergence of antimicrobial resistance. However, it remains unclear how to best design CS-based treatment schedules. To address this problem, we use mathematical modelling to study the effects of pathogen- and drug-specific characteristics for different treatment designs on bacterial population dynamics and resistance evolution. We confirm that simultaneous and one-day cycling treatments could supress resistance in the presence of CS. We show that the efficacy of CS-based cycling therapies depends critically on the order of drug administration. Finally, we find that reciprocal CS is not essential to suppress resistance, a result that significantly broadens treatment options given the ubiquity of one-way CS in pathogens. Overall, our analyses identify key design principles of CS-based treatment strategies and provide guidance to develop treatment schedules to suppress resistance. |
format | Online Article Text |
id | pubmed-8479078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84790782021-10-22 Design principles of collateral sensitivity-based dosing strategies Aulin, Linda B. S. Liakopoulos, Apostolos van der Graaf, Piet H. Rozen, Daniel E. van Hasselt, J. G. Coen Nat Commun Article Collateral sensitivity (CS)-based antibiotic treatments, where increased resistance to one antibiotic leads to increased sensitivity to a second antibiotic, may have the potential to limit the emergence of antimicrobial resistance. However, it remains unclear how to best design CS-based treatment schedules. To address this problem, we use mathematical modelling to study the effects of pathogen- and drug-specific characteristics for different treatment designs on bacterial population dynamics and resistance evolution. We confirm that simultaneous and one-day cycling treatments could supress resistance in the presence of CS. We show that the efficacy of CS-based cycling therapies depends critically on the order of drug administration. Finally, we find that reciprocal CS is not essential to suppress resistance, a result that significantly broadens treatment options given the ubiquity of one-way CS in pathogens. Overall, our analyses identify key design principles of CS-based treatment strategies and provide guidance to develop treatment schedules to suppress resistance. Nature Publishing Group UK 2021-09-28 /pmc/articles/PMC8479078/ /pubmed/34584086 http://dx.doi.org/10.1038/s41467-021-25927-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Aulin, Linda B. S. Liakopoulos, Apostolos van der Graaf, Piet H. Rozen, Daniel E. van Hasselt, J. G. Coen Design principles of collateral sensitivity-based dosing strategies |
title | Design principles of collateral sensitivity-based dosing strategies |
title_full | Design principles of collateral sensitivity-based dosing strategies |
title_fullStr | Design principles of collateral sensitivity-based dosing strategies |
title_full_unstemmed | Design principles of collateral sensitivity-based dosing strategies |
title_short | Design principles of collateral sensitivity-based dosing strategies |
title_sort | design principles of collateral sensitivity-based dosing strategies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479078/ https://www.ncbi.nlm.nih.gov/pubmed/34584086 http://dx.doi.org/10.1038/s41467-021-25927-3 |
work_keys_str_mv | AT aulinlindabs designprinciplesofcollateralsensitivitybaseddosingstrategies AT liakopoulosapostolos designprinciplesofcollateralsensitivitybaseddosingstrategies AT vandergraafpieth designprinciplesofcollateralsensitivitybaseddosingstrategies AT rozendaniele designprinciplesofcollateralsensitivitybaseddosingstrategies AT vanhasseltjgcoen designprinciplesofcollateralsensitivitybaseddosingstrategies |